AZN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.04%

Insider Buying (Last 12 Months): £2,233,160

Insider Selling (Last 12 Months): GBX 0

AstraZeneca Insider Trading History Chart

AstraZeneca Share Price & Price History

£118.82

▲ +232.001 (1.99%)

As of 03/13/2025 01:40 PM ET

Days: 30 | 90 | 365

AstraZeneca Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/19/2024	Tony Mok	Insider	Buy	1,500	£126.80	£190,200
11/14/2024	Pascal Soriot	Insider	Buy	20,000	£102.03	£2,040,600
9/13/2024	Michel Demare	Insider	Buy	2,000	GBX 118	£2,360
12/12/2023	Anna Manz	Insider	Buy	487	£101.90	£49,625.30
11/22/2023	Michel Demare	Insider	Buy	1,000	£101.70	£101,700
4/28/2023	Michel Demare	Insider	Buy	2,000	£117.01	£234,020

SEC Filings (Institutional Ownership Changes) for AstraZeneca (LON:AZN)

51.03% of AstraZeneca stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

Today's Range

Now: £118.82

£116.44

£118.98

50 Day Range

MA: £114.06

£105.94

£120.72

52 Week Range

Now: £118.82

9,670

£133.88

Volume

74,387,414 shs

Average Volume

29,232,170 shs

Market Capitalization

£228.61 billion

P/E Ratio

32.57

Dividend Yield

1.23%

Beta

0.17

Who are the company insiders with the largest holdings of AstraZeneca?: AstraZeneca's top insider shareholders include:
Anna Manz (Insider)
Michel Demare (Insider)
Pascal Soriot (Insider)
Tony Mok (Insider)
Learn More about top insider investors at AstraZeneca.